Merck Off The Hook In Fosamax Fracture Suit, Judge Rules

Law360, Los Angeles (June 27, 2013, 9:34 PM EDT) -- A New Jersey federal judge on Thursday said claims that Merck & Co. failed to warn a consumer of the possible risk of femur fractures from the use of its bone drug Fosamax are preempted under federal law because the U.S. Food and Drug Administration refused to strengthen the drug's label the year the consumer was injured.

U.S. District Judge Joel A. Pisano granted Merck summary judgment on the failure to warn question Thursday, effectively terminating Bernadette Glynn's lawsuit against the company. Glynn claimed she suffered a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

MOLNAR et al v. MERCK & CO., INC.


Case Number

3:08-cv-00008

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Judge

Freda L. Wolfson

Date Filed

January 2, 2008

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.